HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Figures and Tables All Versions of this Article: 38/3/281    most recent 00047.2009v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Google Scholar Articles by Dai, P. Articles by Wu, B.-L. PubMed PubMed Citation Articles by Dai, P. Articles by Wu, B.-L.

Translational Physiology

Distinct and novel SLC26A4/Pendrin mutations in Chinese and U.S. patients with nonsyndromic hearing loss

¹ Department of Otorhinolaryngology Head and Neck Surgery and Genetic Testing Center for Deafness, PLA General Hospital, Beijing, People's Republic of China
² Renal Division and Molecular and Vascular Medicine Unit, Beth Israel Deaconess Medical Center, Boston, Massachusetts
³ Department of Pediatrics, Rambam Medical Center and Department of Physiology and Biophysics, Technion School of Medicine, Haifa, Israel
⁴ Department of Laboratory Medicine
⁵ Department of Otolaryngology
⁶ Division of Genetics, Children's Hospital Boston
⁷ Harvard Medical School, Boston, Massachusetts
⁸ Institutes of Biomedical Science, Fudan University, Shanghai, People's Republic of China

Mutations of the human SLC26A4/PDS gene constitute the most common cause of syndromic and nonsyndromic hearing loss. Definition of the SLC26A4 mutation spectrum among different populations with sensorineural hearing loss is important for development of optimal genetic screening services for congenital hearing impairment. We screened for SLC26A4 mutations among Chinese and U.S. subjects with hearing loss, using denaturing HPLC (DHPLC) and direct DNA sequencing. Fifty-two of 55 Chinese subjects with deafness accompanied by enlargement of the vestibular aqueduct (EVA) exhibited at least one mutant SLC26A4 allele, whereas SLC26A4 mutations were found in only 2 of 116 deaf Chinese patients without EVA. The spectrum of SLC26A4 mutations differed among Chinese and U.S. subjects and included 10 previously unreported SLC26A4 variants: 4 in the Chinese population (p.E303Q, p.X329, p.X467, p.X573) and 6 in the U.S. population (p.V250A, p.D266N, p.F354S, p.D697A, p.K715N, p.E737D). Among the seven novel in-frame missense mutations, five encoded SLC26A4 proteins with substantially reduced Cl^–/anion exchange activity as expressed and measured in Xenopus oocytes, but four of these were sufficiently active to allow study of anion selectivity. The only mutant polypeptide exhibiting complete loss of anion exchange function, p.E303Q, was expressed at or near the oocyte surface at near-wild-type levels. Two variants, p.F354S and p.E737D, displayed selective reduction in relative rate of Cl^–/HCO₃^– exchange compared with similarly measured rates of Cl^–/Cl^– and Cl^–/I^– exchange. Our data show that mutation analysis of the SLC26A4 gene is of high diagnostic yield among subjects with deafness and bilateral EVA in both China and the U.S. However, the pathogenicity of monoallelic SLC26A4 gene variants in patients with hearing loss remains unclear in many instances.

Pendred syndrome; chloride/bicarbonate exchange; iodide transport; enlargement of vestibular aqueduct; goiter

This article has been cited by other articles:

				C. Runge-Samuelson and M. Olivier The rocky road toward clinical genetic testing: insights into the physio-genetic basis of hearing loss Physiol Genomics, October 1, 2009; 39(2): 83 - 84. [Full Text] [PDF]